title: Recent recommendations on steroid-induced osteoporosis: more targeted, but more complicated.
abstract: The latest recommendations for preventing and treating glucocorticoid-induced osteoporosis, published by the American College of Rheumatology (ACR) in 2010, incorporate developments that occurred since the release of its 2001 guidelines, such as new drugs and the World Health Organization's Fracture Risk Assessment Tool, or FRAX. They outline a more targeted approach but have the possible disadvantage of being more complicated and therefore harder to use.
authors: Department of Rheumatic and Immunologic Disease, Cleveland Clinic, Cleveland, OH 44195, USA. dealc@ccf.org
authors: Chad L
authors: CL
authors: Deal
mesh_terms: D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D050723:Fractures, Bone / Q000517:prevention & control*; D005938:Glucocorticoids / Q000009:adverse effects*; D006801:Humans; D010024:Osteoporosis / Q000139:chemically induced / Q000517:prevention & control*; D017410:Practice Guidelines as Topic; D012219:Rheumatology / Q000592:standards; D018570:Risk Assessment
chemical_list: D050071:Bone Density Conservation Agents; D005938:Glucocorticoids